uroVision Gesellschaft für medizinischen Technologie-Transfer mbH

uroVision Gesellschaft fuer medizinischen Technologie-Transfer mbH develops, manufactures and sells medical devices, in particular in the field of urology. For the 2017 financial year the company reported sales of EUR 15,371,241.96. Profit after taxes amounted to EUR 2,057,374.28 but was fully transferred to the shareholder under a profit transfer agreement amounting to EUR 2,054,424.67, resulting in a net profit of EUR 0.00. The balance sheet shows receivables from affiliated companies of EUR 10,786,478.40, inventories of EUR 980,884.59 (of which goods EUR 980,133.45) and equity of EUR 9,926,044.17; the average number of employees was 28.